| 000 | 01735 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515233239.0 | ||
| 264 | 0 | _c20100812 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1532-0979 | ||
| 024 | 7 |
_a10.1097/PAS.0b013e3181e7740d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCapper, David | |
| 245 | 0 | 0 |
_aApplication of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. _h[electronic resource] |
| 260 |
_bThe American journal of surgical pathology _cAug 2010 |
||
| 300 |
_a1199-204 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aBrain Neoplasms _xenzymology |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aGlioma _xenzymology |
| 650 | 0 | 4 |
_aGliosis _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aIsocitrate Dehydrogenase _xanalysis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeuroglia _xenzymology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
| 650 | 0 | 4 |
_aWT1 Proteins _xanalysis |
| 700 | 1 | _aSahm, Felix | |
| 700 | 1 | _aHartmann, Christian | |
| 700 | 1 | _aMeyermann, Richard | |
| 700 | 1 | _avon Deimling, Andreas | |
| 700 | 1 | _aSchittenhelm, Jens | |
| 773 | 0 |
_tThe American journal of surgical pathology _gvol. 34 _gno. 8 _gp. 1199-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/PAS.0b013e3181e7740d _zAvailable from publisher's website |
| 999 |
_c20001133 _d20001133 |
||